Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 533 du 21 juillet 2022
Lutte contre les cancers
Qualité de vie, soins de support (1)
Menée à partir de données portant sur 474 patients atteints d'un cancer traité par chimiothérapie à base d'anthracycline entre 2009 et 2014 (192 cas de cancer du sein, 184 cas de lymphome, 98 cas de sarcome ; age médian : 61 ans), cette étude rétrospective analyse l'association entre un indice mesurant la masse musculaire des pectoraux et la survenue d'événements cardiaques indésirables induits par les traitements anticancéreux ainsi que la survie
Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: retrospective study
Menée à partir de données portant sur 474 patients atteints d'un cancer traité par chimiothérapie à base d'anthracycline entre 2009 et 2014 (192 cas de cancer du sein, 184 cas de lymphome, 98 cas de sarcome ; age médian : 61 ans), cette étude rétrospective analyse l'association entre un indice mesurant la masse musculaire des pectoraux et la survenue d'événements cardiaques indésirables induits par les traitements anticancéreux ainsi que la survie
Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: retrospective study
Toama, Wael ; Wiederin, Jason ; Shanley, Ryan ; Jewett, Patricia ; Gu, Christina ; Shenoy, Chetan ; Nijjar, Prabhjot S. ; Blaes, Anne H.
Introduction : The impact of pectoralis muscle mass index (PMI) on cardiac events is not well studied in cancer patients, especially in those who have received chemotherapy with high potential cardiac toxicity such as anthracyclines. Methods : Individuals aged ≥18 years with a diagnosis of breast cancer, sarcoma, or lymphoma who received anthracycline-based chemotherapy at the University of Minnesota MHealth Fairview between 2009 and 2014. Eligible patients had to have two CT scans: a baseline [...]
Observation (6)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer:...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study
Lee, Lennard Y. W. ; Ionescu, Maria C. ; Starkey, Thomas ; Little, Martin ; Tilby, Michael ; Tripathy, Arvind R. ; McKenzie, Hayley S. ; Al-Hajji, Youssra ; Appanna, Nathan ; Barnard, Matthew ; Benny, Liza ; Burnett, Alexander ; Cattell, Emma L. ; Clark, James J. ; Khan, Sam ; Ghafoor, Qamar ; Panneerselvam, ; Illsley, George ; Harper-Wynne, Catherine ; Hattersley, Rosie J. ; Lee, Alvin J. X. ; Lomas, Oliver ; Liu, Justin K. H. ; McCauley, Amanda ; Pang, Matthew ; Pascoe, Jennifer S. ; Platt, James R. ; Patel, Grisma ; Patel, Vijay ; Potter, Vanessa A. ; Randle, Amelia ; Rigg, Anne S. ; Robinson, Tim M. ; Roques, Tom W. ; Roux, Rene L. ; Rozmanowski, Stefan ; Taylor, Harriet ; Tuthill, Mark H. ; Watts, Isabella ; Williams, Sarah ; Beggs, Andrew ; Iveson, Tim ; Lee, Siow Ming ; Middleton, Gary ; Middleton, Mark ; Protheroe, Andrew ; Fittall, Matthew W. ; Fowler, Tom ; Johnson, Prof Peter
Purpose : People living with cancer and haematological malignancies are at increased risk of hospitalisation and death following infection with acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus third dose vaccine boosters are proposed to boost waning immune responses in immunocompromised individuals and increase coronavirus protection; however, their effectiveness has not yet been systematically evaluated. Methods : This study is a population-scale real-world evaluation of the [...]
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic
Patel, Manali I. ; Ferguson, Jacqueline M. ; Castro, Eida ; Pereira-Estremera, Cristina D. ; Armaiz-Pena, Guillermo N. ; Duron, Ysabel ; Hlubocky, Fay ; Infantado, Analynn ; Nuqui, Bles ; Julian, Donna ; Nortey, Nii ; Steck, Alexandra ; Bondy, Melissa ; Maingi, Shail
The full effect of the COVID-19 pandemic on cancer care disparities, particularly by race and ethnicity, remains unknown.To assess whether the race and ethnicity of patients with cancer was associated with disparities in cancer treatment delays, adverse social and economic effects, and concerns during the COVID-19 pandemic and to evaluate trusted sources of COVID-19 information by race and ethnicity.This national survey study of US adults with cancer compared treatment delays, adverse social [...]
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
Russell, Beth ; Moss, Charlotte ; Monroy-Iglesias, Maria ; Roberts, Graham ; Dickinson, Harvey ; Haire, Kate ; Innes, Kathryn ; Mulji-Shah, Bansi ; Castell, Fiona ; Al-Salihi, Omar ; Lei, Mary ; Francis, Angela ; Dann, Bill ; Jogia, Vikash ; Hamid, Hisham ; Challacombe, Ben ; Simo, Ricard ; Fraser, Stephanie ; Gousis, Charalampos ; Sawyer, Elinor ; Tsotra, Eirini ; Roca, Jose ; Khan, Muhammad ; Josephs, Debra ; Enting, Deborah ; Van Hemelrijck, Mieke ; Harris, Victoria ; Dolly, Saoirse
Background : During the COVID pandemic, there was a paucity of data to support clinical decision-making for anticancer treatments. We evaluated the safety of radical treatments which were delivered whilst mitigating the risks of concurrent COVID-19 infection. Methods : Using descriptive statistics, we report on the characteristics and short-term clinical outcomes of patients undergoing radical cancer treatment during the first COVID-19 wave compared to a similar pre-pandemic period. Results : [...]
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
Zaleska, Joanna ; Kwasnik, Paulina ; Paziewska, Magdalena ; Purkot, Joanna ; Szabelak, Aleksandra ; Jurek, Mateusz ; Masny, Natalia ; Dziatkiewicz, Izabela ; Pronobis-Szczylik, Bartosz ; Piebiak, Agnieszka ; Szymczyk, Agnieszka ; Jarosz-Chudzik, Katarzyna ; Bolkun, Lukasz ; Kozlowska, Katarzyna ; Piszcz, Jaroslaw ; Subocz, Edyta ; Halka, Janusz ; Bator, Michał ; Kalicinska, Elzbieta ; Wrobel, Tomasz ; Usnarska-Zubkiewicz, Lidia ; Rybka, Justyna ; Deren-Wagemann, Izabela ; Szyca-Smieszniak, Marta ; Dybko, Jaroslaw ; Hus, Iwona ; Pula, Bartosz ; Cichocka, Edyta ; Rymko, Marcin ; Zdunczyk, Dorota ; Ziarkiewicz, Mateusz ; Basak, Grzegorz Wladyslaw ; Bullinger, Lars ; Giannopoulos, Krzysztof
Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) patients have increased morbidity and mortality rates of COVID-19 due to immunosuppression associated with the disease and ongoing therapy. The same immune impairment accompanying CLL and MM also affects suboptimal vaccine response. The study assessed the effectiveness of the humoral and T cell-mediated immunity following mRNA COVID-19 vaccination (using either BNT162b2 or mRNA-1273) in short-term (2-5 weeks after 2nd dose) and [...]
Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrence
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrence
Zalpoor, Hamidreza ; Akbari, Abdullatif ; Nayerain Jazi, Negar ; Liaghat, Mahsa ; Bakhtiyari, Maryam
COVID-19 infection is a serious threat to patients with primary diseases, especially multiple cancers. Studies suggest that cancer patients are one of the most susceptible populations to experience severe COVID-19 and death. In addition, a number of studies suggest various mechanisms for SARS-CoV-2 in cancer progression. In this study, we discussed the role of SARS-CoV-2 in the induction of autophagy and we hypothesized that autophagy induced by COVID-19 not only can contribute to viral [...]
Menée en Guadeloupe à partir de données 2008-2017 du registre des cancers, cette étude analyse l'évolution des disparités géographiques dans l'incidence des cancers
Geographical variations of cancer incidence in Guadeloupe, French West Indies
Menée en Guadeloupe à partir de données 2008-2017 du registre des cancers, cette étude analyse l'évolution des disparités géographiques dans l'incidence des cancers
Geographical variations of cancer incidence in Guadeloupe, French West Indies
Bhakkan-Mambir, Bernard ; Deloumeaux, Jacqueline ; Luce, Danièle
Background : Geographical disparities in cancer incidence are observed at different scales and may highlight areas of high risk that need special attention to improve health policies. In Guadeloupe, a French archipelago in the Caribbean, environmental and socioeconomic factors are potential factors associated with cancer incidence. Our objective was to describe geographical variations of cancer incidence in Guadeloupe at a small-area level, in order to identify potential clusters. Methods : We [...]
Cette étude présente une estimation, au niveau mondial, de l'incidence du myélome multiple pour l'année 2020 et de la mortalité spécifique
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
Cette étude présente une estimation, au niveau mondial, de l'incidence du myélome multiple pour l'année 2020 et de la mortalité spécifique
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
Huang, Junjie ; Chan, Sze Chai ; Lok, Veeleah ; Zhang, Lin ; Lucero-Prisno, Don Eliseo, III ; Xu, Wanghong ; Zheng, Zhi-Jie ; Elcarte, Edmar ; Withers, Mellissa ; Wong, Martin C. S.
Background : Multiple myeloma accounted for 176 404 (14%) of 1 278 362 the incidence cases leukaemia, lymphoma, and multiple myeloma in 2020. Identifying its geographical distribution, risk factors, and epidemiological trends could help identify high-risk population groups. We aimed to examine the worldwide incidence, mortality, associated risk factors, and temporal trends of multiple myeloma by sex, age, and geographical region. Methods : The incidence and mortality of multiple myeloma were [...]
Improving the global reporting of multiple myeloma: a focus on low-income and middle-income countries
Cette étude présente une estimation, au niveau mondial, de l'incidence du myélome multiple pour l'année 2020 et de la mortalité spécifique
Improving the global reporting of multiple myeloma: a focus on low-income and middle-income countries
Swaminathan, Rajaraman ; Mehra, Nikita
The findings reported by Junjie Huang and colleagues, published in The Lancet Haematology, elaborate on the recent trends in the epidemiology of multiple myeloma through several global cancer registries, emphasising the contribution of modifiable risk factors, namely overweight and physical inactivity, towards the development of multiple myeloma. The age-standardised multiple myeloma incidence was 1·78 (95% UI 1·69–1·87) per 100 000 people globally and mortality was 1·14 (95% UI 1·07–1·21) per [...]
Menée au Danemark à partir de données portant sur 8 461 patientes ménopausées et ayant survécu à un cancer du sein ER+ de stade précoce diagnostiqué entre 1997 et 2004 (durée médiane de suivi : 9,8 ans), cette étude analyse le risque de récidive et la mortalité associés à l'utilisation d'une hormonothérapie (oestrogénothérapie vaginale ou traitement hormonal substitutif)
Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
Menée au Danemark à partir de données portant sur 8 461 patientes ménopausées et ayant survécu à un cancer du sein ER+ de stade précoce diagnostiqué entre 1997 et 2004 (durée médiane de suivi : 9,8 ans), cette étude analyse le risque de récidive et la mortalité associés à l'utilisation d'une hormonothérapie (oestrogénothérapie vaginale ou traitement hormonal substitutif)
Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
Cold, Søren ; Cold, Frederik ; Jensen, Maj-Britt ; Cronin-Fenton, Deirdre ; Christiansen, Peer ; Ejlertsen, Bent
Women treated for breast cancer (BC) often suffer genitourinary syndrome of menopause. These symptoms may be alleviated by vaginal estrogen therapy (VET) or menopausal hormone therapy (MHT). However, there are concerns of risks of recurrence of BC and death following treatment.Our study included longitudinal data from a national cohort of postmenopausal women, diagnosed 1997-2004 with early-stage invasive estrogen receptor–positive nonmetastatic BC, who received no treatment or 5 years of [...]
Vaginal Estrogen Therapy for the Genitourinary Symptoms of Menopause: Caution or Reassurance?
Menée au Danemark à partir de données portant sur 8 461 patientes ménopausées et ayant survécu à un cancer du sein ER+ de stade précoce diagnostiqué entre 1997 et 2004 (durée médiane de suivi : 9,8 ans), cette étude analyse le risque de récidive et la mortalité associés à l'utilisation d'une hormonothérapie (oestrogénothérapie vaginale ou traitement hormonal substitutif)
Vaginal Estrogen Therapy for the Genitourinary Symptoms of Menopause: Caution or Reassurance?
Cathcart-Rake, Elizabeth J ; Ruddy, Kathryn J
Vasomotor symptoms (hot flashes and night sweats) and genitourinary symptoms (vaginal dryness, dysuria, urinary tract infections, and dyspareunia) frequently plague breast cancer survivors during adjuvant endocrine therapy (1). These symptoms worsen quality of life and can contribute to early treatment discontinuation, such that supplemental estrogens are sometimes considered to mitigate these endocrine therapy toxicities. However, the safety of systemic and vaginal estrogen use among breast [...]
Menée à partir des données 1990-2017 du registre finlandais des cancers, cette étude analyse l'évolution de l'incidence des tumeurs du système nerveux central chez les enfants (âge : 0-14 ans)
Incidence trends of childhood central nervous system tumors in Finland 1990–2017
Menée à partir des données 1990-2017 du registre finlandais des cancers, cette étude analyse l'évolution de l'incidence des tumeurs du système nerveux central chez les enfants (âge : 0-14 ans)
Incidence trends of childhood central nervous system tumors in Finland 1990–2017
Abuhamed, Jad ; Nikkilä, Atte ; Raitanen, Jani ; Alimam, Wafa ; Lohi, Olli ; Pitkäniemi, Janne ; Haapasalo, Hannu ; Auvinen, Anssi
Introduction : Central nervous system (CNS) tumors are a leading cause of cancer-related morbidity and mortality in children. Our aim is to characterize incidence trends of pediatric CNS tumors in Finland over the last three decades. Methods : Data on all benign and malignant incident CNS tumors diagnosed in children aged 0–14 years in 1990–2017 were extracted from the Finnish Cancer Registry and classified according to the 2016 WHO classification of CNS tumors. We analyzed age-standardized [...]
Cet article analyse la prise en charge de l'épilepsie chez les patients atteints d'une tumeur cérébrale
Management of epilepsy in brain tumor patients
Cet article analyse la prise en charge de l'épilepsie chez les patients atteints d'une tumeur cérébrale
Management of epilepsy in brain tumor patients
Van der Meer, Pim B. ; Taphoorn, Martin J.B. ; Koekkoek, Johan A.F.
Isocitrate dehydrogenase mutation and its active metabolite d-2-hydroxyglutarate seem important contributing factors to epileptogenesis. Antiepileptic drug (AED) levetiracetam seems the preferred choice in brain tumor-related epilepsy. In case of inadequate seizure control on AED monotherapy, potential add-on AEDs include lacosamide, perampanel, and valproic acid. In the end-of-life phase when oral intake of medication is hampered, benzodiazepines via nonoral administration routes are potential [...]
Approches psycho-sociales (3)
Mené sur 192 patients atteints d'un cancer de la prostate de stade avancé, cet essai randomisé évalue l'intérêt, pour réduire les symptômes et améliorer la qualité de vie, d'une intervention collective de gestion du stress dispensée sur tablette
Who benefits from an eHealth-based stress management intervention in advanced prostate cancer? Results from a randomized controlled trial
Mené sur 192 patients atteints d'un cancer de la prostate de stade avancé, cet essai randomisé évalue l'intérêt, pour réduire les symptômes et améliorer la qualité de vie, d'une intervention collective de gestion du stress dispensée sur tablette
Who benefits from an eHealth-based stress management intervention in advanced prostate cancer? Results from a randomized controlled trial
Benzo, Roberto M. ; Moreno, Patricia I. ; Noriega-Esquives, Blanca ; Otto, Amy K. ; Penedo, Frank J.
Objective : Conduct a secondary analysis to examine the effects of a tablet-delivered, group-based cognitive-behavioral stress management (CBSM) intervention for reducing symptom burden among men with advanced prostate cancer (APC) and elevated baseline levels of symptom burden Methods : A total of 192 men with APC were randomized to either a CBSM or a health promotion condition and followed for one year. Six analytical samples were included in our study, each including participants who [...]
Menée à partir de données portant sur des patientes ayant survécu à un cancer du sein, cette étude de cohorte rétrospective analyse l'association entre une neuropathie périphérique induite par la chimiothérapie et le risque de dépression et d'anxiété
Chemotherapy-induced peripheral neuropathy onset is associated with early risk of depression and anxiety in breast cancer survivors
Menée à partir de données portant sur des patientes ayant survécu à un cancer du sein, cette étude de cohorte rétrospective analyse l'association entre une neuropathie périphérique induite par la chimiothérapie et le risque de dépression et d'anxiété
Chemotherapy-induced peripheral neuropathy onset is associated with early risk of depression and anxiety in breast cancer survivors
McNeish, Brendan L. ; Richardson, James K. ; Whitney, Daniel G.
Objective : The objective was to assess for an association between chemotherapy-induced peripheral neuropathy (CIPN) onset and development of depression and anxiety in breast cancer (BrCa) survivors. Methods : A retrospective observational cohort was used and identified from Optum's De-identified Clinformatics® Data Mart Database years 2012–2015. Three groups of women were derived based on BrCa and CIPN status: BrCa+/CIPN+ (n = 244), BrCa+/CIPN− (n = 8870), and BrCa−/CIPN− (n = 1,125,711). The [...]
A partir d'une revue systématique de la littérature publiée entre 1994 et 2022 (7 études), cette méta-analyse évalue l'effet de soins concernant l'apparence physique sur la santé psychosociale de patientes attteintes d'un cancer du sein (estime de soi, anxieté, dépression, sexualité)
Effects of the appearance care on psychosocial outcomes for breast cancer: a systematic review and meta-analysis
A partir d'une revue systématique de la littérature publiée entre 1994 et 2022 (7 études), cette méta-analyse évalue l'effet de soins concernant l'apparence physique sur la santé psychosociale de patientes attteintes d'un cancer du sein (estime de soi, anxieté, dépression, sexualité)
Effects of the appearance care on psychosocial outcomes for breast cancer: a systematic review and meta-analysis
Zhu, Mengyao ; Sun, Shihao ; Zhang, Yiheng ; Chen, Lili ; He, Haiyan ; Chen, Juanjuan ; Zhang, Ni ; Zhang, Meifen
Purpose : To synthesize the evidence for the immediate and short-term effects of appearance care on psychosocial outcomes in breast cancer patients in order to inform the design of future research and clinical practice. Methods : A search of four databases (PubMed, Embase, Cochrane Central Register of Controlled Trials, and Web of Science). The JBI Critical Appraisal Checklists were used by two reviewers to assess methodology quality. Subgroup analysis was conducted for the different time [...]
Sensibilisation et communication (1)
Menée aux Etats-Unis auprès de 53 parents atteints d'un cancer, cette étude analyse l'intérêt d'une intervention psychosociale en ligne pour les aider à parler de la maladie avec leurs enfants
Families Addressing Cancer Together (FACT): feasibility and acceptability of a web-based psychosocial intervention for parents with cancer
Menée aux Etats-Unis auprès de 53 parents atteints d'un cancer, cette étude analyse l'intérêt d'une intervention psychosociale en ligne pour les aider à parler de la maladie avec leurs enfants
Families Addressing Cancer Together (FACT): feasibility and acceptability of a web-based psychosocial intervention for parents with cancer
Park, Eliza M. ; Deal, Allison M. ; Heiling, Hillary M. ; Jung, Ahrang ; Yopp, Justin M. ; Bowers, Savannah M. ; Hanson, Laura C. ; Song, Mi-Kyung ; Valle, Carmina G. ; Yi, Brian ; Cassidy, Anna ; Won, Hannah ; Rosenstein, Donald L.
Purpose : Although parents with cancer report that talking with their children about cancer and dying is distressing, accessible support is rare. We assessed the feasibility, acceptability, and preliminary effects of Families Addressing Cancer Together (FACT), a web-based, tailored psychosocial intervention to help parents talk about their cancer with their children. Methods : This pilot study used a pre-posttest design. Eligible participants were parents with new or metastatic solid tumors who [...]
Soins palliatifs (2)
A partir d'une revue de la littérature (25 essais randomisés incluant un total de 5 160 patients), cette méta-analyse évalue l'effet des soins palliatifs sur la qualité de vie des patients adultes atteints d'un cancer de stade avancé
Impact of palliative care on quality of life in advanced cancer: A meta-analysis of randomised controlled trials
A partir d'une revue de la littérature (25 essais randomisés incluant un total de 5 160 patients), cette méta-analyse évalue l'effet des soins palliatifs sur la qualité de vie des patients adultes atteints d'un cancer de stade avancé
Impact of palliative care on quality of life in advanced cancer: A meta-analysis of randomised controlled trials
Hoomani Majdabadi, Fatemeh ; Ashktorab, Tahereh ; Ilkhani, Mahnaz
Introduction : This study aimed to examine the impact of palliative care on the life quality of adults with advanced cancer. Methods : After a comprehensive and regular search using [MeSH] keywords in some important databases, 25 published randomised controlled trials (RCTs) involving 5160 adults with advanced cancer were selected and examined through meta-analysis. Results : Analysis of 36 reports in 1–3 months follow-up, and 19 reports in 4–7 months follow-up, showed that compared to usual [...]
A partir d'une revue sytématique de la littérature (57 études), cette étude analyse les différents outils permettant d'évaluer et de prendre en charge la fatigue liée à la maladie chez des patients atteints d'un cancer et recevant des soins palliatifs
Cancer-related fatigue measures in palliative care: A psychometric systematic review
A partir d'une revue sytématique de la littérature (57 études), cette étude analyse les différents outils permettant d'évaluer et de prendre en charge la fatigue liée à la maladie chez des patients atteints d'un cancer et recevant des soins palliatifs
Cancer-related fatigue measures in palliative care: A psychometric systematic review
Montagut-Martínez, Pedro ; Pérez-Cruzado, David ; Gutiérrez-Sánchez, Daniel
Introduction : In palliative care, the prevention and relief of fatigue are regarded as crucial goals in patients with cancer. Methods : A systematic review was carried out according to the COnsensus-based Standards for the selection of health status Measurement INstruments methodology. Searches were conducted in Medline (through PubMed), Web of Science, Open Gray, Scielo, Cochrane, CINAHL and EMBASE. All instruments found in each study were assessed using the COnsensus-based Standards for the [...]
Ethique (1)
Cet article identifie les problèmes éthiques liés à l'utilisation des technologies de l'intelligence artificielle en cancérologie et propose une feuille de route pour le déploiement de ces technologies
A Process Framework for Ethically Deploying Artificial Intelligence in Oncology
Cet article identifie les problèmes éthiques liés à l'utilisation des technologies de l'intelligence artificielle en cancérologie et propose une feuille de route pour le déploiement de ces technologies
A Process Framework for Ethically Deploying Artificial Intelligence in Oncology
Hantel, Andrew ; Clancy, Dillon D. ; Kehl, Kenneth L. ; Marron, Jonathan M. ; Van Allen, Eliezer M. ; Abel, Gregory A.
Artificial Intelligence (AI) is an emerging technology that uses complex algorithms to arrive at an outcome over a range of circumstances, leveraging the ability of computer systems to perform tasks that would usually require human levels of intelligence.1-3 The use of AI in cancer care is rapidly expanding: a May 2022 PubMed search of the term cross-referenced with cancer revealed approximately 26,000 citations, with more than 60% published in the past five years. Ethical considerations for AI [...]
Médecines parallèles (1)
Menée en Allemagne, cette étude analyse les informations concernant les médecines complémentaires et alternatives communiquées par les médecins généralistes à leurs patients atteints d'un cancer
General practitioners' communication on complementary and integrative medicine for cancer patients: Findings from an analysis of consultations with...
Menée en Allemagne, cette étude analyse les informations concernant les médecines complémentaires et alternatives communiquées par les médecins généralistes à leurs patients atteints d'un cancer
General practitioners' communication on complementary and integrative medicine for cancer patients: Findings from an analysis of consultations with standardised patients
Engler, Jennifer ; Güthlin, Corina ; Bertram, Laura ; Tesky, Valentina ; Schall, Arthur ; Joos, Stefanie ; Valentini, Jan
Objective : Our aim was to explore whether general practitioners (GPs) communicate with cancer patients on complementary and integrative medicine (CIM) in a patient-centred and case-specific manner. Methods : We designed two cases of standardised breast cancer patients and allocated 29 GPs to hold a consultation either with Case 1 or Case 2. Case 1 presented with fears of possible physical side effects of hormone treatment. Case 2 feared a loss in social functioning because of nausea and emesis [...]
